INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

GMEDGLOBUS MEDICAL INC

CIK 0001237831

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells3 / 1
Max Insider Score28
Connections4with evidence

GMED · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
RD
Rhoads Ann DDirector
GMEDGLOBUS MEDICAL INC
Open-market sale · 10b5-1 plan
SELL$425K
5,000 sh
Nov 4, 2026Nov 5, 2026
traded Nov 4, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • ← Insider ofevidence
    Rhoads Ann DDirector · Nov 5, 2026
  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-09-10 · Sep 10, 2026
  • ← Lobbied forevidence
    BALLARD SPAHR LLPLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
24
Gilbert Ray Cisneros, Jr.DSelf
GMEDGLOBUS MEDICAL INC
Purchase
BUY
$1,001 – $15K
Sep 3, 2026
Oct 12, 2026
traded Sep 3, 2026
+39d
HOUSE PTR

Evidence

24
Gilbert Ray Cisneros, Jr.DSelf
GMEDGLOBUS MEDICAL INC
Purchase
BUY$15K – $50KAug 19, 2026Sep 10, 2026
traded Aug 19, 2026
+22dHOUSE PTR

Evidence

28
Gilbert Ray Cisneros, Jr.DSelf
GMEDGLOBUS MEDICAL INC
Purchase
BUY$1,001 – $15KMar 3, 2026Apr 7, 2026
traded Mar 3, 2026
+35dHOUSE PTR

Evidence

Lobbying

$0 reported · de-duplicated
2026 Q2 $0 via firms2026 Q1 $0 via firms
  • BALLARD SPAHR LLP—2026 Q1 · posted Aug 26, 2026 ·
  • BALLARD SPAHR LLP—2026 Q2 · posted Aug 26, 2026 ·

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.